MiMedx Group (NASDAQ:MDXG – Get Free Report) is set to issue its quarterly earnings data after the market closes on Wednesday, October 30th. Analysts expect the company to announce earnings of $0.05 per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.
MiMedx Group (NASDAQ:MDXG – Get Free Report) last announced its quarterly earnings results on Wednesday, July 31st. The company reported $0.08 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.08. The company had revenue of $87.21 million during the quarter, compared to analysts’ expectations of $88.44 million. MiMedx Group had a return on equity of 34.24% and a net margin of 23.63%. On average, analysts expect MiMedx Group to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
MiMedx Group Stock Performance
Shares of NASDAQ MDXG opened at $5.86 on Tuesday. The business’s 50-day simple moving average is $6.08 and its 200-day simple moving average is $6.67. The company has a debt-to-equity ratio of 0.11, a quick ratio of 3.22 and a current ratio of 3.85. MiMedx Group has a 52 week low of $5.47 and a 52 week high of $9.27. The firm has a market cap of $864.96 million, a price-to-earnings ratio of 13.32 and a beta of 1.97.
Analysts Set New Price Targets
MiMedx Group Company Profile
MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins.
See Also
- Five stocks we like better than MiMedx Group
- Stock Dividend Cuts Happen Are You Ready?
- Inflation Risk Rising, Key Trades Investors Are Making Now
- What is the NASDAQ Stock Exchange?
- 3 Oil Stocks to Watch Before Earnings Come Out
- What is the S&P 500 and How It is Distinct from Other Indexes
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
Receive News & Ratings for MiMedx Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiMedx Group and related companies with MarketBeat.com's FREE daily email newsletter.